Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Merck & Co., Inc.
  6. Calendar
    MRK   US58933Y1055

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart MERCK & CO., INC.
Upcoming events on MERCK & CO., INC.
12/14/21 Ex-dividend day for
02/03/22 FY 2021 Earnings Release
02/03/22 | 08:00am FY 2021 Earnings Call
04/28/22 Q1 2022 Earnings Release
04/28/22 | 08:00am Q1 2022 Earnings Call
07/28/22 Interim 2022 Earnings Release
07/28/22 | 08:00am Interim 2022 Earnings Call
10/27/22 Q3 2022 Earnings Release
10/27/22 | 08:00am Q3 2022 Earnings Call
02/02/23 FY 2022 Earnings Release (Projected)
Past events on MERCK & CO., INC.
12/01/21 | 10:30am Evercore ISI HealthCONx Conference
11/20/21 | 11:00am American Society of Tropical Medicine and Hygiene Meeting - LB-5319
10/28/21 | 08:00am Q3 2021 Earnings Call
10/28/21 | 06:30am Q3 2021 Earnings Release
09/30/21 | 08:00am Acquisition of Acceleron Pharma Inc. by Merck & Co., Inc. Call
09/20/21 | 04:30pm ESMO Congress Conference
09/14/21 Ex-dividend day for
09/13/21 | 11:00am Morgan Stanley Global Healthcare Conference
07/29/21 | 08:00am Interim 2021 Earnings Call
07/29/21 | 06:30am Interim 2021 Earnings Release
Past dividends on MERCK & CO., INC.
09/14/21 Quarterly 0.65 USD
06/14/21 Quarterly 0.65 USD
06/03/21 0
03/12/21 Quarterly 0.65 USD
12/14/20 Quarterly 0.65 USD
09/14/20 Quarterly 0.61 USD
06/12/20 Quarterly 0.61 USD
03/13/20 Quarterly 0.61 USD
12/13/19 Quarterly 0.61 USD
09/13/19 Quarterly 0.55 USD
Annual results
Fiscal Period : December201620172018201920202021
Sales
M $		 Released
Forecast
Spread		39 807
39 991
-0,46%		40 122
40 205
-0,21%		42 294
42 234
0,14%		46 840
46 818
0,05%		47 994
48 177
-0,38%		 
48 576
 
Operating income
(EBITDA)
M $		 Released
Forecast
Spread		19 154
19 083
0,37%		15 131
15 472
-2,2%		15 781
15 310
3,1%		19 572
18 761
4,3%		20 570
19 815
3,8%		 
19 747
 
Operating profit
(EBIT)
M $		 Released
Forecast
Spread		13 713
13 698
0,11%		13 551
13 722
-1,2%		13 926
13 815
0,80%		15 920
16 276
-2,2%		16 945
17 366
-2,4%		 
17 650
 
Pre-Tax Profit
(EBT)
M $		 Released
Forecast
Spread		7 499
7 288
2,9%		6 747
6 720
0,40%		8 701
8 296
4,9%		11 464
12 277
-6,6%		8 791
14 906
-41%		 
8 572
 
Net income
M $		 Released
Forecast
Spread		5 691
5 779
-1,5%		2 568
5 147
-50%		6 220
6 462
-3,7%		9 843
9 957
-1,1%		7 067
12 094
-42%		 
12 378
 
EPS
$		 Released
Forecast
Spread		2,04
2,03
0,57%		0,93
1,85
-50%		2,32
2,44
-5,0%		3,81
3,83
-0,52%		2,78
4,71
-41%		 
4,86
 
Announcement Date02/02/201702/02/201802/01/201902/05/202002/04/2021-
Quarterly results
Fiscal Period : December2020 Q32020 Q42021 Q12021 Q22021 Q32021 Q4
Sales
M $		 Released
Forecast
Spread		12 551
12 213
2,8%		12 514
12 668
-1,2%		12 080
12 648
-4,5%		11 402
11 193
1,9%		13 154
12 320
6,8%		 
13 150
 
Operating income
(EBITDA)
M $		 Released
Forecast
Spread		5 744
4 862
18%		4 608
4 606
0,04%		5 220
5 416
-3,6%		4 659
4 555
2,3%		6 111
5 175
18%		 
4 703
 
Operating profit
(EBIT)
M $		 Released
Forecast
Spread		4 892
4 342
13%		3 704
4 047
-8,5%		4 290
4 844
-11%		3 969
4 032
-1,6%		5 352
4 708
14%		 
4 504
 
Pre-Tax Profit
(EBT)
M $		 Released
Forecast
Spread

 

 

 		1 717
3 367
-49%

 		 

 
Net income
M $		 Released
Forecast
Spread		2 941
2 575
14%		-2 094
2 773
-176%		3 179
3 712
-14%		1 214
2 805
-57%		4 567
3 078
48%		 
3 422
 
EPS
$		 Released
Forecast
Spread		1,16
1,02
14%		-0,83
1,05
-179%		1,25
1,43
-13%		0,48
0,82
-41%		1,80
1,35
33%		 
1,27
 
Announcement Date10/27/202002/04/202104/29/202107/29/202110/28/2021-
Previous year Next Year
Upcoming sector events for MERCK & CO., INC.
More events
Past sector events for MERCK & CO., INC.
11/03/21 | 01:30am NOVO NORDISK A/S :
11/02/21 | 05:45am PFIZER INC. :
10/26/21 | 06:25am ELI LILLY AND COMPANY :
10/20/21 | 01:00am ROCHE HOLDING AG :
10/19/21 | 06:25am JOHNSON & JOHNSON :
08/04/21 | 10:24am NOVO NORDISK A/S :
08/03/21 | 06:25am ELI LILLY AND COMPANY :
07/28/21 | 06:45am PFIZER INC. :
07/22/21 | 01:00am ROCHE HOLDING AG :
07/21/21 | 06:25am JOHNSON & JOHNSON :
More events
Analysis
Merck sees up to $7 billion in sales of COVID-19 drug through end of 2022
Stock Pick
 MERCK AND COMPANY
Leader in oncology, modest valuation
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise